Oncolytic virus platform to treat hematological cancer
US-12569526-B2 · Mar 10, 2026 · US
This page is not indexed by search engines while we improve data quality.
Mcfadden Douglas Grant patents
Mcfadden Douglas Grant is listed as an inventor on 17 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Mcfadden Douglas Grant |
| Total patents | 17 |
| First publication | Dec 29, 2016 |
| Latest publication | Mar 10, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Methods for improved poxvirus yields
US-12398375-B2 · Aug 26, 2025 · US
Oncolytic virus platform to treat cancers with myxoma virus
US-12331079-B2 · Jun 17, 2025 · US
Methods of treating cancer with TNF expressing myxoma virus
US-12257278-B2 · Mar 25, 2025 · US
Use of aav-expressed m013 protein as an anti-inflammatory therapeutic
US-2024101607-A1 · Mar 28, 2024 · US
Oncolytic viruses that express multi-specific immune cell engagers
US-2024093158-A1 · Mar 21, 2024 · US
Oncolytic virus comprising immunomodulatory transgenes and uses thereof
US-2024091284-A1 · Mar 21, 2024 · US
Use of AAV-expressed M013 protein as an anti-inflammatory therapeutic
US-11685767-B2 · Jun 27, 2023 · US
Methods and compositions for improving oncolytic virus infection for nonpermissive cancers
US-2022296660-A1 · Sep 22, 2022 · US
A new oncolytic virus platform to treat cancers with myxoma virus
US-2021324014-A1 · Oct 21, 2021 · US
Recent patents
Latest publications not already listed above.
Methods for improved poxvirus yields
US-2021301263-A1 · Sep 30, 2021 · US
Oncolytic virus platform to treat cancers with myxoma virus
US-11117934-B2 · Sep 14, 2021 · US
Methods of treating cancer with tnf expressing myxoma virus
US-2021268050-A1 · Sep 2, 2021 · US
Oncolytic virus platform to treat hematological cancer
US-2021252086-A1 · Aug 19, 2021 · US
New oncolytic virus platform to treat cancers with myxoma virus
US-2021061864-A1 · Mar 4, 2021 · US
Use of a combination of myxoma virus and rapamycin for therapeutic treatment
US-2018256656-A1 · Sep 13, 2018 · US
Use of aav-expressed m013 protein as an anti-inflammatory therapeutic
US-2016376325-A1 · Dec 29, 2016 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ Arizona State | 13 |
| Univ Florida | 3 |
| Oncomyx Therapeutics Inc | 3 |
| Univ Western Ontario | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12N7/00 | 16 |
| C12N15/86 | 14 |
| A61K35/768 | 12 |
| C12N2710/24043 | 11 |
| C12N2710/24032 | 10 |